Released: 6-Jan-2023 12:55 PM EST

Vaccine and prior SARS-CoV-2 infection confer long-lasting protection against omicron BA.5


Instituto de Medicina Molecular

A new study led by Luís Graça, group leader at the Instituto de Medicina Molecular João Lobo Antunes (iMM, Lisbon) and full professor at the Medical School of the University of Lisbon, and Manuel Carmo Gomes, associate professor with aggregation at the Faculty of Sciences of the University of Lisbon (Ciências ULisboa), both members of the Direção Geral de Saúde (DGS) Technical Committee for Vaccination against COVID-19 (CTVC), and published today in the scientific journal Lancet Infectious Diseases*, shows that the protection conferred by hybrid immunity against the SARS-CoV-2 subvariant omicron BA.5, obtained by the infection of vaccinated people, lasts for at least eight months after the first infection.



Newswise Expert Queries

Source link

You May Also Like

Trump Org.’s longtime CFO testifies at company’s fraud trial

NEW YORK — Donald Trump’s longtime finance chief took the witness stand…

Cozy up to “Glass Onion,” the droll “Knives Out” sequel that delivers all the murder mystery goods

After the success of his 2019 whodunit “Knives Out,” writer/director Rian Johnson…

6 dead, 1 critically hurt at house fire; murder investigation underway

A man was arrested for the attempted murder of the surviving victim.…

Twitter’s Ban on Kanye West Violates Its Own Policies

Twitter’s decision to ban Kanye West raises interesting issues about freedom of…